Ankit Mahadevia

Form D signer

Ankit Mahadevia

Chief Executive Officer at Antlia Bioscience

Form D signer

Capital raised by Antlia Bioscience

$6.0M+$6.0M latest round

1 Form D filing · first filed May 2026 · Encinitas, CA

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: —

Career

1 company on file

Antlia BioscienceBiotech · Encinitas, CAsince May 2026

Chief Executive Officer

Signatory on Antlia Bioscience's Form D filings · $6.0M raised across 1

Company filings

via EDGAR · Form D for Antlia Bioscience1

DateCompanyFormAmountRole on filing

May 22, 2026Antlia BioscienceForm D+$6.0MChief Executive Officer

Form DMay 22, 2026 · Antlia Bioscience+$6.0Mas Chief Executive Officer

Overview

Last filing May 22, 2026

Ankit Mahadevia is on file as Chief Executive Officer at Antlia Bioscience in Encinitas, CA. Antlia Bioscience has 1 Form D filing on record, $6.0M raised in total. Ankit Mahadevia appears as a signatory on the company's filings.

LinkedIn profile

Teammates

Antlia Bioscience · 1

Martin TaylorDirector

Products

Antlia Bioscience · 1

PASylated long-acting peptide program for chronic heart failurePreclinical therapeutic program

A preclinical therapeutic program applying XL-protein's PASylation technology to a cardiovascular peptide, extending its plasma half-life so it can be developed as a chronic treatment for heart failure.